Picture loading failed.

Anti-CD47 therapeutic antibody (Pre-made Magrolimab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-333-1mg 1mg 3090
GMP-Bios-ab-333-10mg 10mg 21890
GMP-Bios-ab-333-100mg 100mg 148000
GMP-Bios-ab-333-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-CD47 therapeutic antibody (Pre-made Magrolimab biosimilar,Whole mAb)
INN Name Magrolimab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusActive
100% SI StructureNone
99% SI Structure5iwl:AA:BB
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
CompaniesForty Seven;Merck KGaA;Stanford University
Conditions Approvedna
Conditions ActiveDiffuse large B cell lymphoma;Follicular lymphoma;Non-Hodgkin's lymphoma;Colorectal cancer;Solid tumours;Acute myeloid leukaemia;Myelodysplastic syndromes;Ovarian cancer
Conditions DiscontinuedLymphoma
Development Techna